11:14 AM EDT, 05/28/2024 (MT Newswires) -- Zentek ( ZTEK ) was advancing in recent trading on Tuesday after the technology development and commercialization company said it has received a second patent from the Canadian Intellectual Property Office protecting the active ingredient in its ZenGUARD antimicrobial agent.

The patent covers Zentek's ( ZTEK ) nanocomposite form of graphene oxide and cationic silver and its use in liquid, powder and ointment forms to help prevent and eliminate biofilms on medical and veterinarian devices and assissting with wound care in humans or pets.

The company said it has also applied with the US Patent and Trademark Office seeking protection for the compound.

Zentek ( ZTEK ) shares were up more than 2% in mid-morning trading in light volume on the Nasdaq Capital Market. The stock also trades on the TSXV market in Canada, climbing 2% on Tuesday and adding to a fractional gain on Monday that followed the company announcing the patent award while the US markets were closed for the Memorial Day holiday.

Price: 1.11, Change: +0.02, Percent Change: +2.31